FDA Re-evaluating Drug Data Generated By Fraudulent Clinical Investigator

FDA is reviewing data related to drug studies conducted by clinical investigator Robert Fiddes, MD, to ensure the safety and effectiveness of products for which he falsified clinical trial data.